Biovail Laboratories (2005) Inc.
Records under this name other than patents Biovail Laboratories (2005) Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Biovail Laboratories (2005) Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,780,987 | Controlled Release Dosage Forms Formerly held Term ended Term ended Mar 23, 2025 · High confidence | Term ended | Term ended Mar 23, 2025 | High confidence |
| US 7,537,784 | Modified Release Tablet of Bupropion Hydrochloride Formerly held Term ended Term ended Jun 5, 2024 · Medium confidence | Term ended | Term ended Jun 5, 2024 | Medium confidence |
| US 8,128,957 | Modified Release Compositions of at Least One Form of Tramadol Formerly held Lapsed on the fee record Ended Mar 6, 2020 · Low confidence | Lapsed on the fee record | Ended Mar 6, 2020 | Low confidence |
| US 6,143,327 | Delayed release coated tablet of bupropion hydrochloride Formerly held Term ended Term ended Dec 13, 2019 · USPTO record | Term ended | Term ended Dec 13, 2019 | USPTO record |
| US 6,033,686 | Controlled release tablet of bupropion hydrochloride Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,096,341 | Delayed release tablet of bupropion hydrochloride Formerly held Term ended Term ended Oct 30, 2018 · USPTO record | Term ended | Term ended Oct 30, 2018 | USPTO record |
| US 6,967,218 | Pravastatin Pharmaceutical Formulations and Methods of Their Use Formerly held Lapsed on the fee record Ended Nov 22, 2017 · High confidence | Lapsed on the fee record | Ended Nov 22, 2017 | High confidence |
| US 6,368,628 | Sustained release pharmaceutical composition free of food effect Lapsed on the fee record Ended Apr 9, 2014 · USPTO record | Lapsed on the fee record | Ended Apr 9, 2014 | USPTO record |
| US 6,348,469 | Solid compositions containing glipizide and polyethylene oxide Formerly held Lapsed on the fee record Ended Feb 19, 2014 · USPTO record | Lapsed on the fee record | Ended Feb 19, 2014 | USPTO record |
| US 6,117,453 | Solid compositions containing polyethylene oxide and an active ingredient Formerly held Lapsed on the fee record Ended Sep 12, 2012 · USPTO record | Lapsed on the fee record | Ended Sep 12, 2012 | USPTO record |